Target-Based Drug Discovery in Medicinal Chemistry: Innovative Approaches and Future Directions

Abstract

Target-based drug discovery remains a primary strategy in  medicinal chemistry for developing selective and effective therapeutics. This paper reviews innovative approaches that enhance target identification, validation, and modulation, including chemical biology tools, proteomics, and CRISPR- based gene editing. The focus is on how these technologies facilitate a deeper understanding of disease biology and enable the rational design of molecules that precisely interact with their biological targets. The paper also discusses challenges related to target druggability, off-target effects, and resistance mechanisms. Innovations such as allosteric modulation,  multi-target  drugs, and covalent binding are examined as strategies to overcome these hurdles. Through case studies of successful target-based drugs, the paper demonstrates how medicinal chemistry innovations have translated biological insights into impactful therapies. Future perspectives highlight the integration of systems biology and personalized medicine approaches to refine target selection and drug design.

KEYWORDS: Medicinal Chemistry, Target-Based Drug Discovery, Chemical Biology, Proteomics, Allosteric Modulation